Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-02-25 @ 7:03 PM
Study NCT ID:
NCT04537234
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2020-08-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-26
First Submit QC Date:
None
Study First Post Date:
2020-09-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-08
Results First Submit QC Date:
None
Results First Post Date:
2021-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-19
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED